FDA 483 - Trilogy Laboratories, LLC - August 27, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Trilogy Laboratories, LLC in Fort Myers, FL, revealed numerous significant cGMP deficiencies. The firm lacks a functional quality control unit, adequate laboratory controls, and proper stability data to support drug product expiration dates. Additionally, manufacturing processes are unvalidated, and batch and master production records are incomplete or absent, indicating a systemic failure to ensure the quality and purity of their topical human drug products.
ID · 4f9670ba-7ea2-4356-8022-04efb9565596